Skip to search.
 FTSE 100 Down 0.29%

Gilead Sciences Inc. (GILD)

-NasdaqGS
79.12 Up 1.26(1.62%) 30 Sep 21:00
|After Hours: : 79.39 Up 0.27 (0.34%) 1 Oct 00:57
Prev Close:77.86
Open:78.06
Bid:79.15 x 200
Ask:79.39 x 100
1y Target Est:103.50
Beta:1.00055
Next Earnings Date: 1-Nov-16GILD Earnings announcement
Day's Range:78.05 - 79.63
52wk Range:76.67 - 111.11
Volume:11,031,540
Avg Vol (3m):10,503,600
Market Cap:104.41b
P/E (ttm):6.94
EPS (ttm):11.39
Div & Yield:1.88 (2.37%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDUp 1.62%104.41b
GSKUp 0.54%102.67b
PFEUp 1.65%205.44b

Key Statistics

Forward P/E (1 yr):6.85
P/S (ttm):3.17
Ex-Dividend Date:14-Sep-16

Analysts

Annual EPS Est (Dec-16) :11.76
Quarterly EPS Est (Sep-16) :2.88
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-32.05

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback